MDxHealth SA (MDXH)
| Market Cap | 119.13M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 30.24M |
| EPS (ttm) | -2.10 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 65,877 |
| Open | 4.00 |
| Previous Close | 4.01 |
| Day's Range | 3.80 - 4.04 |
| 52-Week Range | 0.35 - 7.60 |
| Beta | -347,291.10 |
| Analysts | Strong Buy |
| Price Target | 6.67 (+69.29%) |
| Earnings Date | Nov 8, 2023 |
About MDXH
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October ... [Read more]
Financial Performance
In 2022, MDxHealth's revenue was $37.05 million, an increase of 66.62% compared to the previous year's $22.24 million. Losses were -$44.04 million, 51.9% more than in 2021.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for MDXH stock is "Strong Buy." The 12-month stock price forecast is $6.67, which is an increase of 69.29% from the latest price.
News
MDxHealth Announces Completion of Transition to Single Listing on Nasdaq
NEWS RELEASE – REGULATED INFORMATION DECEMBER 18, 2023, 1:00 AM ET / 07:00 AM CET MDxHealth Announces Completion of Transition to Single Listing on Nasdaq IRVINE, CA, and HERSTAL, BELGIUM...
MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq
NEWS RELEASE – REGULATED INFORMATION NOVEMBER 27, 2023, 1:00 am ET / 7:00 am CET MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nas...
MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference
NEWS RELEASE November 14, 2023, 4PM ET/ 22:00 CET MDxHealth to Participate in the 35 th Annual Piper Sandler Healthcare Conference IRVINE, CA, and HERSTAL, BELGIUM – November 14, 2023 – MDxHealth SA (...
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023
NEWS RELEASE – REGULATED INFORMATION 8 NOVEMBER 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023 IRVINE, CA, and ...
MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation
NEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION NOVEMBER 6, 2023, 1:00 AM ET / 7:00 CET
MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8
NEWS RELEASE 25 OCTOBER 2023, 4PM ET / 22:00 CET MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8 Company to Host Conference Call with Live Q&A, November 8,...
Mdxhealth's New Share Capital Amount and New Number of Shares
NEWS RELEASE - REGULATED INFORMATION October 20, 2023 , 4:00 PM EDT / 22:00 CET
MDxHealth Reports Preliminary Q3-2023 Revenues
NEWS RELEASE – INSIDE AND REGULATED INFORMATION 9 OCTOBER 2023, 4PM ET / 22:00 CET MDxHealth Reports Preliminary Q3-2023 Revenues IRVINE, CA, and HERSTAL, BELGIUM – October 9, 2023 – MDxHe...
MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting
NEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION OCTOBER 2, 2023, 4:00pm ET / 22:00 CET
Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer
NEWS RELEASE September 26 , 202 3 , 5 :00PM EDT / 23:00 CET
MDxHealth Reports Q2 and Half Year 2023 Results
NEWS RELEASE – REGULATED INFORMATION 23 AUGUST 202 3 , 4:00PM EDT / 22:00 CET
MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23
NEWS RELEASE 10 AUGUST 202 3 , 4 PM ET / 22:00 CET
Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth's Select mdx for Prostate Cancer Test
Expansion of coverage with Cigna now includes full menu of Company's precision diagnostic prostate cancer tests, representing more than 15 million lives under coverage.
MDxHealth Announces Results of its Extraordinary General Shareholders' Meeting
NEWS RELEASE - REGULATED INFORMATION 30 June 2023 , 10:00 p.m. CE S T
MDxHealth Announces its Extraordinary General Shareholders' Meeting
NEWS RELEASE – REGULATED INFORMATION JUNE 5 , 2023, 5 :30 pm ET/ 2 3 :30 CE S T MDxHealth Announces its Extraordinary General Shareholders' Meeting IRVINE, CA, and HERSTAL, BELGIUM – June 5, 2023 – MD...
MDxHealth Announces Results of its Annual and Extraordinary General Shareholders' Meetings
NEWS RELEASE - REGULATED INFORMATION 25 May 2023 , 22:30 CET
MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference
NEWS RELEASE May 23 , 2023, 4 PM ET/ 22: 0 0 CET MDxHealth to Present at the 43 rd Annual William Blair Growth Stock Conference IRVINE, CA, and HERSTAL, BELGIUM – May 23, 2023 – MDxHealth SA (Nasdaq a...
MDxHealth Reports Q1-2023 Results
NEWS RELEASE - REGULATED INFORMATION 15 MAY 202 3 , 4:00PM EDT / 22:00 CET
MDxHealth to Present First Quarter 2023 Financial Results on May 15
NEWS RELEASE 1 MAY 202 3 , 4PM ET / 22 :00 CET
MDxHealth Announces its Ordinary and Extraordinary General Shareholders' Meetings
NEWS RELEASE – REGULATED INFORMATION APRIL 2 5 , 2023, 4: 00 pm ET/ 22: 00 CET
MDxHealth Shareholder Transparency Declaration
IRVINE, CA, and HERSTAL, BELGIUM – April 7, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, announces today i...
MDxHealth Confirms No Exposure to Silicon Valley Bank or Silvergate Bank
IRVINE, CA, and HERSTAL, BELGIUM – March 13, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today confirms that neither MDxHealth SA, nor any of its sub...
MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023
NEWS RELEASE - REGULATED INFORMATION 8 MARCH 202 3 , 4 : 0 0 PM EST / 22:00 CET
MDxHealth Announces Exercise of Option
NEWS RELEASE – REGULATED INFORMATION
MDxHealth Shareholder Transparency Declarations
IRVINE, CA, and HERSTAL, BELGIUM – March 3, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, announces today i...